Isoxazole-pyrimidine derivatives as TACC3 inhibitors: A novel modality to targeted cancer therapy

Q: How does OCRA curate its research paper database?

OCRA indexes peer-reviewed papers from PubMed and CrossRef, enriched with MeSH terms, author profiles, and citation metrics. Papers are categorized by cancer type, research method, and clinical relevance.

Q: Can I search papers by MeSH term or author?

Yes. Use the search bar to filter papers by MeSH term, author name, journal, keyword, or cancer type. Each paper includes linked MeSH terms and author profiles for further exploration.

Q: How current is the paper database?

The database is updated regularly through automated ingestion from PubMed and CrossRef. Most papers appear within days of their PubMed indexing date.

doi:10.1016/j.bioorg.2025.108204

Isoxazole-pyrimidine derivatives as TACC3 inhibitors: A novel modality to targeted cancer therapy

Deniz Lengerli & Erden Banoglu et al. · 2025-01-24

Links

DOI PubMed

Journal

Bioorganic Chemistry

Authors

Deniz Lengerli, Özge Akbulut Çalışkan, Kübra Çalışkan, Özge Saatci, Chaemin Lim, Sridhar Vempati, Burcu Çalışkan, Özgür Şahin, Erden Banoglu

Funding

AMAG Pharmaceuticals Funding